Related by context. All words. (Click for frequent words.) 64 ACCORD Eye 62 Scandinavian Simvastatin Survival 62 PFO migraine 61 running Zutphen Elderly 61 Ocular Hypertension Treatment 60 ExTRACT TIMI 60 SIMPADICO 60 Breakthrough Generations 60 Car Naturalistic Driving 60 APEX AMI trial 59 STRIDE PD 59 prospective multicentre 59 RE LY 59 Sherlock uncovering 58 Carotid Revascularization Endarterectomy vs. 58 EMPOWER ™ 58 ECASS 57 Phase III HEAT 57 Canadian Multicentre Osteoporosis 57 Acetonide 57 MEND CABG 57 CALERIE 57 Nord Trøndelag Health 56 CARE HF 56 Sibutramine Cardiovascular Outcomes 56 NBN Implementation 56 OPT CHF 56 Osteoporotic Fractures 56 MEND CABG II 56 cortical stimulation 56 Wisconsin Sleep Cohort 56 AVERROES 56 Aggressive Reduction 55 APPRAISE 55 Prostate Cancer Outcomes 55 British Gambling Prevalence 55 EchoCRT 55 landmark ATHENA 55 MERLIN TIMI 55 Acute Liver Failure 55 Women Ischemia Syndrome 55 brown baggers #x# 55 Asthma Intervention 55 phase IIIb 55 Phase III ADT 55 Intervention Effectiveness CATIE 55 Epidemiologic Follow 54 EVEREST II 54 Multicenter 54 HYVET 54 Edge STudy 54 PARTNER Trial 54 Evaluation WISE 54 TRA 2P 54 Home Buyer Seller 54 LUX Lung 54 Thrombolysis 54 TIMI Study Group 54 SPARCL 54 Cholesterol Levels SPARCL 54 BRIM3 54 Debit Issuer 54 PCI ExTRACT TIMI 53 Stenting Trial CREST 53 Glucosamine Chondroitin Arthritis 53 AIR2 Trial 53 Multicenter Automatic Defibrillator Implantation 53 COSTAR II 53 prospective multicenter 53 LUMINATE 53 Dubbo Osteoporosis Epidemiology 53 Acute Coronary Syndromes 53 MIST II 53 Bankruptcies soar 53 Alzheimer Disease Cooperative 53 VADT 53 Disciple Bible 53 CAPRIE 53 MADIT II 53 TAXUS IV 53 Subgroup analysis 53 PRIMO CABG 53 ACTIVE W 53 Prostate Cancer Prevention 52 ONTARGET 52 RE LY ® 52 ACRIN 52 Digital Mammographic Imaging 52 multicenter randomized controlled 52 placebo controlled clinical 52 APEX PD 52 Stenting Trial 52 ADMIRE HF 52 Diabetes ACCORD 52 TRITON TIMI 52 Echocardiographic 52 Randomized Evaluation 52 PFO closure 52 ORACLE MS 52 ACCORD Lipid 52 kitchen wine cellars 52 NO# [002] 52 PIX# [002] 52 HF ACTION 52 KN excels 52 prospective longitudinal 52 BARI 2D 52 Cancer Prevention ATBC 52 EMBLEM TM 52 Bioethical Issues 52 BCIRG 52 multicenter prospective 52 STICH trial 52 Patient Outcomes 52 ORAL Solo 52 multicentre prospective 52 PRIMO CABG2 52 Screening Trial DMIST 51 carotid artery stenting CAS 51 prospective nonrandomized 51 ZYBRESTAT TM 51 Bayer HealthCare Onyx Pharmaceuticals 51 Multicenter Phase 51 Insulin Resistance Atherosclerosis 51 PROTECT II 51 pain palliation 51 Nesiritide 51 ACCEDE 51 ASCO Breast Cancer 51 ACCLAIM II 51 riociguat 51 RECORD1 51 Investigator Initiated 51 Trandolapril 51 placebo controlled multicenter 51 SCD HeFT 51 ongoing Phase IIIb 51 multicenter randomized clinical 51 Intervention Effectiveness 51 Male Ageing 51 PROTECT AF 51 Clinical Antipsychotic Trials 51 Randomized controlled 51 Val HeFT 51 Zevalin consolidation 51 ENDEAVOR III 51 intracranial stenosis 50 Non Alcoholic Steatohepatitis 50 ZYBRESTAT fosbretabulin 50 randomized multicenter 50 Uncontrolled hypertension 50 blinded randomized placebo controlled 50 initiated confirmatory Phase 50 BR.# 50 Vertos II 50 prospective observational cohort 50 placebo controlled dose escalation 50 ENDEAVOR IV 50 morphometric vertebral fractures 50 EURIDIS 50 confirmatory clinical 50 NATRECOR R 50 POISE 50 CHAMPION PCI 50 AVADO 50 conducted retrospective cohort 50 Liraglutide Effect 50 multicentre randomized 50 Practice Patterns 50 Prostate Disease 50 HORIZONS AMI trial 50 Traumatic Encephalopathy CSTE 50 carotid atherosclerosis 50 nonrandomized 50 Western Airborne Contaminants 50 Microalbuminuria 50 nonfasting triglycerides 50 eritoran 50 ARBITER 6 50 Acute Decompensated Heart Failure 50 Evidence Therapeutic 50 Empirical Legal 50 AVOREN 50 NEVO RES 50 RIO Lipids 50 Complications Trial 50 REVIVE Diabetes 50 CABANA 50 bought Glaxo Serevent 50 IMPROVE HF 50 ACUITY trial 50 ASSERT 50 meta regression 50 evaluating mipomersen 50 Endovascular Valve Edge 50 ONCONASE R 50 Urocortin 2 50 TMC# C# 50 Histological 50 SPIRIT IV 50 EMPOWER TM 49 AIM HIGH 49 RE LY trial 49 PREVAIL 49 ENGAGE AF TIMI 49 pivotal bioequivalence 49 Prospective Multicenter 49 TAXUS V 49 ALLHAT 49 NICE SUGAR 49 PREVENT IV 49 CONSORT 49 Cerebrovascular Diseases 49 ASTEROID 49 prospective randomized multicenter 49 initiate multicenter 49 Health Initiative Observational 49 CALGB 49 randomized Phase 2b 49 GISSI 49 phase Ib 49 PERSEUS 49 Histologic 49 SYNTAX 49 Bogalusa Heart 49 Non inferiority 49 Kaplan Meier analysis 49 Coronary Heart Disease 49 PROactive 49 Septic Shock 49 STEP BD 49 NIHSS score 49 prospectively defined 49 carotid artery narrowing 49 Dunedin Multidisciplinary Health 49 Partnership Attitude Tracking 49 prognostic variables 49 PRESEPT 49 Intervention Trial GAIT 49 recurrent venous thromboembolism 49 SWiTCH 49 EAT Eating 49 transcranial Doppler ultrasound 49 pharmacokinetic PK 49 Thorough QT 49 viral kinetic 49 clinicopathological 48 PCPT 48 Percutaneous Coronary Intervention 48 MSI #F 48 Dialysis Outcomes 48 ILLUSTRATE 48 HeFT 48 adenoma recurrence 48 Phase 2b RESTORE CLI 48 SORT OUT III 48 Decompensated Heart Failure 48 perioperative mortality 48 Multicenter AIDS 48 DSMB recommended 48 Cardiac Resynchronization Therapy 48 observational cohort 48 Dr. Kandzari 48 CARDIA 48 NATRECOR ® 48 Arterial Hypertension 48 mildly symptomatic 48 TAXUS ATLAS 48 MADIT 48 Molecular Genetic 48 Phase IIIb 48 Anticoagulation 48 MDRD 48 CATIE AD 48 NSABP 48 prelicensure 48 cerebral microbleeds 48 recurrent glioblastoma multiforme 48 PreCISe 48 ICON7 48 BLOOM Behavioral modification 48 CIPN 48 International Verapamil SR 48 phase III SIMPADICO 48 CIMZIA ™ 48 iPrEx 48 Digestive Diseases Week 48 methodologic 48 subclinical hypothyroidism 48 visit http:/www.clinicaltrials.gov/ 48 surveys Herbenick 48 afatinib 48 Cost Avoidance 48 Hepatotoxicity 48 Therapeutic Arthritis 48 TQT 48 PROACT 48 venous thromboembolic disease 48 lorcaserin Phase 48 ruboxistaurin 48 MADIT CRT 48 HoFH 48 REALITY Trial 48 Memory Study WHIMS 48 ezetimibe simvastatin 48 Tor Bjerkedal report 48 TWYNSTA 48 Coronary Artery Calcium 48 Endocrine Practice 48 HORIZONS AMI 48 Outpatient Setting 48 initiate Phase IIb 48 CONQUER OB 48 PLCO 47 Adverse Childhood 47 MARVEL Trial 47 silent ischemia 47 Meta analyzes 47 meta analysis pooling 47 ASCEND HF 47 DMIST 47 symptomatic VTE 47 atherosclerotic renal artery stenosis 47 GISSI HF 47 Untreated Syphilis 47 subgroup analyzes 47 Subgroup analyzes 47 Pharmacodynamic 47 Debt Affordability 47 rALLy clinical trial 47 PRECISE 47 bazedoxifene conjugated estrogens 47 multivariate logistic regression 47 premed Reynolds 47 IMPACT IMmunotherapy 47 Hypertriglyceridemia 47 Phase 1a clinical 47 postmenopausal estrogen 47 chromium supplementation 47 childhood acute lymphoblastic 47 PERISCOPE 47 PITX2 methylation 47 retrospective observational 47 Screening Trial 47 liver metastasis 47 carotid plaque 47 Primary endpoints 47 Larry Cornman physicist 47 endophenotypes 47 colorectal liver metastases 47 ADHF 47 ACCLAIM 47 NCCTG N# 47 Phase 2b kidney transplant 47 Ischemic 47 prostate carcinogenesis 47 enzastaurin 47 COPERNICUS 47 coronary revascularizations 47 relapsed MM 47 PROactive study 47 STRATEGY FOR AN OPEN 47 See CLINICAL PHARMACOLOGY 47 Nephrology Dialysis Transplantation 47 FDG PET imaging 47 zileuton IV 47 subanalysis 47 Randomized clinical trials 47 Sorafenib HCC Assessment 47 TAXUS VI 47 Parkinson Disease PD 47 Ingestive Behavior 47 named RIGOR 47 Francesca Bravi 47 #F FDG PET 47 postmenopausal hormone therapy 47 daytime dozing 47 fallopian tube cancers 47 Ionizing Radiation 47 NSABP C 47 ximelagatran 47 AREDS 47 Clinical Outcomes Utilizing Revascularization 47 SWOG 47 acute ischemic stroke 47 ADVANCE PD 47 periprocedural MI 47 electron beam computed tomography 47 venous thromboembolisms 47 Laryngeal Cancer 47 torcetrapib atorvastatin 47 NSABP B 47 prostate cancer CaP 47 CaPSURE 47 Lipid Lowering Treatment 47 ATACAND 47 atherothrombotic disease 47 Phase IIb III 47 Vietnam Veterans Readjustment 47 ORBIT II 47 TEVAR 47 Afib 46 Chairman Elwood Emm 46 aldosterone antagonist 46 Perinatal Mortality 46 Coronary artery calcification 46 ULORIC 46 myocardial viability 46 Index CDAI 46 cryptogenic stroke 46 MYTHOS trial 46 colorectal adenoma 46 visceral metastases 46 Diabetes Complications 46 STICH 46 lipid abnormality 46 KRAS mutation 46 OpenNotes 46 Antihypertensive 46 Alpha Tocopherol Beta Carotene 46 DAPT Study 46 mg BID dose 46 metachronous 46 CR nPR 46 alvespimycin 46 selenium supplementation 46 Heart Failure Trial 46 SUCCEED trial 46 Lisa Mosconi 46 UNLOAD 46 Delcath Phase III 46 multivariate Cox 46 QTinno TM 46 multivariable adjusted 46 nonfasting triglyceride levels 46 VKORC1 46 WHEL 46 ACC AHA SCAI 46 Multivariate logistic regression 46 Neuroepidemiology 46 HIV HCV coinfected 46 spirometric 46 chemoprevention trials 46 longitudinal cohort study 46 Equity Gilt 46 recurrent glioma 46 Dietary Modification Trial 46 CUSTOM II 46 Biological Effects 46 Ceplene/IL-2 46 author Richard Lapchick 46 biliary tract cancer 46 ACCF AHA 46 PACCE trial 46 schizophrenia CIAS 46 conditional logistic regression 46 beta blocker therapy 46 NABE Outlook 46 neoadjuvant treatment 46 Cholinesterase Inhibitors 46 meta analytic 46 AVN# Phase 46 Mien Chie Hung 46 varespladib 46 Lung Injury 46 CLARITY TIMI 46 journal Anticancer 46 CYP#D# genotype 46 carotid artery stenting 46 APPROVe trial 46 compound INCB# 46 AML MDS 46 ALSYMPCA 46 PD2i ® 46 GRAVITAS trial 46 CONSERV 46 acetabular fractures 46 retrospective cohort 46 Rosuvastatin 46 periprocedural 46 CSAMT MT 46 multicentre randomized controlled 46 CRMD# 46 initiated Phase Ib 46 ABSORB trial 46 carotid stenting 46 Phase #b/#a 46 LibiGel Phase III 46 Ischaemic 46 controlled multicenter 46 carotid artery disease 46 Multiple logistic regression 46 arterial thromboembolic events 46 SPIRIT III 46 Ovarian Cancer Screening 46 carotid IMT 46 QUASAR validation study 46 EINSTEIN DVT 46 unblinding 46 adjuvant endocrine therapy 46 Renal Cell Carcinoma RCC 46 percutaneous cryoablation 46 Proteinuria 46 Statin therapy 46 achieved CCyR 46 BEXXAR Therapeutic Regimen 46 carotid artery blockage 46 journal Gynecologic Oncology 46 intraobserver 46 phase III ACCLAIM 46 ERSPC 45 BENICAR HCT 45 tolerability pharmacokinetics 45 NYHA functional class 45 randomized Phase III 45 ADHERE 45 arzoxifene 45 CABERNET 45 Systemic Sclerosis 45 randomized blinded 45 journal Psychological Bulletin 45 Acute MI 45 systolic hypertension 45 biologic plausibility 45 metaanalysis 45 definite stent thrombosis 45 Repeatable Battery 45 Elizabeth Selvin 45 prospective observational studies 45 residual confounding 45 valvulopathy 45 CP CPPS 45 relapsing remitting MS RRMS 45 Dr. Tashkin 45 PLOS 45 CAMMS# 45 GAMMAGARD 45 diabetes mellitus DM 45 Cardiovascular Risk 45 placebo controlled Phase 45 Arch Intern Med 45 Smyrna Gratitude Al Anon 45 COU AA 45 Viola Vaccarino 45 Renal Insufficiency 45 cardioembolic stroke 45 PROSTVAC TM 45 substudy 45 MiDAS 45 Polyp Prevention Trial 45 exercise biomechanics 45 serum leptin 45 Hematologic 45 Ischemic Heart Disease 45 interobserver 45 ImmuKnow assay 45 Framingham Offspring 45 Nalini Ranjit 45 Trial NLST 45 underwent CABG 45 viral kinetics 45 Appropriateness Criteria 45 isoflavone supplement 45 undergone radical prostatectomy 45 LibiGel ® testosterone gel 45 testosterone supplementation 45 Thorough QT Study 45 Relieve Depression 45 EGS# 45 multivariable analysis 45 carotid stenosis 45 urinary N telopeptide 45 PROactive Study 45 Amy Abernethy 45 Prehypertension 45 NAMCS 45 Eugene Braunwald 45 AZOR 45 Alzheimer Disease Genetics 45 mITT population 45 denosumab oncology clinical trials 45 advanced adenoma 45 SYNTAX trial 45 refractory metastatic 45 ID NCT# 45 CTRC AACR San Antonio 45 vaso occlusive crisis 45 Bucindolol 45 CARDIA study 45 noncardiac surgery 45 STARFlex 45 NYHA Class III 45 microalbuminuria 45 ENDEAVOR 45 Hachinski 45 preserved ejection fraction 45 MVax 45 SCAI Annual 45 REGEN trial 45 placebo controlled Phase III 45 GIK infusion 45 StemEx R 45 Corus CAD 45 MADIT CRT trial 45 hyperoxaluria 45 p# biomarker 45 Cardiorespiratory fitness 45 colleague Sana Inoue 45 multiple logistic regression 45 ARDIS 45 logistic regression models 45 dysglycemia 45 Carotid endarterectomy 45 granted Ortec 45 univariate 45 ischemic cardiomyopathy 45 Boston DbTechNo Results 45 Prostate Lung Colorectal 45 serum GGT 45 logistic regression analysis 45 Chicago Multidisciplinary Symposium 45 MelaFind pivotal 45 Renal dysfunction 45 unmeasured confounders 45 BMC Neuroscience 45 KRAS mutation status 45 ASPIRE HIGHER 45 REVIVE TA 45 BETAS 45 Acute Coronary Syndromes ACS 45 journal BJU International 45 REACH Registry 45 Ketotransdel 45 MIVI TRUST 45 Outcome Sciences 45 CYPHER R Sirolimus eluting 45 lipid lowering therapy 45 Qi Dai 45 Dilip V. Jeste 45 cerebrovascular events 45 Lancet Oncology journal 45 dietary modification 45 REVIVE 45 QTinno 45 multivariate analyzes 45 neratinib 45 IMPACT DCM clinical 44 pharmacokinetics PK 44 BRCA testing 44 GVAX Pancreas Vaccine 44 ROCHESTER Minn. Mayo Clinic 44 ABSORB clinical 44 CTEPH 44 TBC# 44 Arterial stiffness 44 unstable angina pectoris 44 ACOSOG Z# 44 Kaplan Meier method 44 polyarticular 44 pharmacokinetic PK study 44 Follicular Lymphoma 44 precancerous colon polyps 44 Xuemei Huang 44 adjuvant radiotherapy 44 randomizing patients 44 PROPEL 44 NHANES III 44 Initiates Phase 2b 44 cutaneous melanoma 44 HOMA IR 44 multiple linear regression 44 Oncotype DX colon cancer 44 intensive lipid lowering 44 LOCF 44 Stroke Risk 44 pharmacokinetic pharmacodynamic 44 carotid intima media 44 Myocardial Infarction 44 thoracic aortic aneurysm 44 intermittent dosing 44 nonfatal MI 44 Sebastian Schneeweiss 44 Endocrine Society #st 44 Hertzel Gerstein 44 lipoprotein Lp 44 Fractional Flow Reserve 44 clinico pathological 44 Cochrane Systematic Review 44 eosinophilic pneumonia 44 placebo fluoxetine 44 genetic polymorphisms 44 TROPIC 44 nonadherence 44 NSTEMI 44 CCCEH 44 venous thromboembolism 44 familial AF 44 orally inhaled migraine 44 Eur Urol 44 Rigorous scientific 44 flurpiridaz F 44 ELCAP 44 Alexandre Abizaid 44 EBMT criteria 44 Venous thromboembolism 44 Interstitial Cystitis 44 persistent pulmonary hypertension 44 Intervention Trial 44 HSCT 44 antioxidant supplementation 44 Study ARIC 44 coronary revascularization 44 evaluating tesamorelin 44 Ezra Susser 44 Camping trivializes 44 Gheorghiade 44 prospectively stratified 44 metastatic pancreatic 44 Luveniq 44 endometriosis ovarian cysts 44 HyQ 44 Cystatin C 44 Observational Study 44 follicular adenoma 44 Patient Registry 44 CHADS2 44 NESARC 44 ABCSG 44 adjuvant radiation 44 Resynchronization 44 Brief Psychiatric 44 multicenter trials 44 everolimus eluting stent 44 lactate dehydrogenase LDH 44 Interpersonal Psychotherapy 44 bronchial hyperresponsiveness 44 suboptimal adherence 44 Duke Comprehensive Cancer 44 thimerosal exposure 44 Logistic regression 44 Boston dbTechno According 44 Lunar Reconnaissance 44 Phase Ib Clinical Trial 44 Hyperlipidemia 44 lacosamide 44 convergent validity 44 APOE genotype 44 aneurysmal subarachnoid hemorrhage 44 COSIRA trial 44 subclinical atherosclerosis 44 intravascular ultrasonography 44 New Retirement Mindscape 44 de novo AML 44 ASCUS 44 ECOG 44 Glucosamine chondroitin Arthritis 44 Mantel Haenszel 44 HER2 expression 44 FOLPI 44 clinicopathologic 44 atherothrombotic 44 palifosfamide 44 AICR WCRF 44 recombinant PSMA vaccine 44 litigation Harvard casebook 44 fidaxomicin Phase 44 INTERHEART study 44 Simin Nikbin Meydani 44 Eye Disease 44 GCP compliant 44 journal CHEST 44 Osteopenia 44 medically inoperable 44 metastatic GIST 44 antiangiogenic therapy 44 Nonalcoholic Fatty Liver Disease 44 serum phosphate 44 registrational trial 44 Young Adults CARDIA 44 Infantile Spasms 44 asymptomatic hyperuricemia 44 Doxil ® 44 HNRCA 44 BMC Musculoskeletal Disorders 44 onset atrial fibrillation 44 Author Contributions 44 esophageal squamous cell carcinoma 44 Stephanie Belloc 44 thrombolytic therapy 44 nesiritide 44 menopausal hormone therapy 44 PLCO trial 44 androgen suppression 44 Haptoglobin 44 Early Lung Cancer 44 methodological limitations 44 OBJECTIVES 44 Clinical Cardiology 44 Shamay Tsoory 44 Cecilia Ramlau Hansen 44 Sequenced Treatment Alternatives 44 ABSSSI 44 budesonide MMX Phase III 44 Comparative Effectiveness 44 & Analgesia retracted 44 distal colon cancer 44 Monique Breteler 44 Homeostasis 44 Non Insulin Dependent 44 thoracoscopic lobectomy 44 Study AREDS 44 PreDx DRS 44 univariate analyzes 44 Mermin oversees 44 neuropathologic 44 histological subtype 44 unstable angina UA 44 Trial PCPT 43 REALISM 43 WHIMS 43 Squamous Cell Carcinoma 43 KIF6 gene variant 43 primary aldosteronism 43 Vasogen Celacade 43 eplerenone 43 Carotid 43 DCCT EDIC 43 corneal ectasia 43 coronary calcification 43 BEIR VII 43 glomerular filtration 43 non valvular atrial 43 Kaplan Meier curve 43 elective percutaneous coronary 43 cardiovascular hospitalization 43 biostatistical analysis 43 Veterans Illnesses 43 Tasigna prolongs 43 HPTN 43 metreleptin 43 EMPHASIS HF 43 Multi Ethnic Study 43 oral anticoagulation 43 SYNTAX Score 43 Cardiac Allograft Rejection 43 PSA kinetics 43 Natural Orifice Surgery 43 histologic subtype 43 Aggressive Drug Evaluation 43 EquiTrend ® 43 NCT# ClinicalTrials.gov 43 Bresalier 43 Pharmacokinetic parameters 43 RTOG 43 STENT 43 CHD CVD 43 CSF biomarkers 43 hepatocellular cancer 43 Implementing Evidence 43 contradicted Metrolink 43 Cockcroft Gault 43 OLYMPIA registry 43 atrasentan 43 Radiation Therapy Oncology 43 COPAXONE R 43 serum uric acid 43 left ventricular systolic 43 MET amplification 43 CAPRA 43 overt nephropathy 43 journal Resuscitation 43 Adult Stem Cell Therapy 43 optimal dosing regimens 43 intracerebral hemorrhage 43 Obstructive Sleep Apnea 43 left ventricular dysfunction 43 prognostic significance 43 lipid lowering drugs 43 preclinical pharmacology 43 Skin sterol 43 T1DM 43 Intercomparison 43 2 diabetes T2D 43 randomized metastatic breast 43 confirmatory pivotal 43 PRESEPT study 43 esophageal varices 43 HDR Decision Economics 43 familial aggregation 43 Soft Tissue Sarcoma 43 folate supplementation 43 Dr. Chenchen Wang 43 attain statistical significance 43 Castration Resistant Prostate Cancer 43 pCR 43 cathepsin K inhibitor 43 cardiovascular morbidity 43 Paul Ridker 43 cTnT levels 43 J Clin Oncol 43 CLL8 43 nondemented 43 Swedish Mammography Cohort 43 prospective observational 43 Myrna Weissman 43 valvular heart 43 Michael Leitzmann 43 Sociodemographic 43 myocardial infarctions MIs 43 exploratory Phase IIa 43 Kantarjian H 43 SNP rs# [002] 43 RIO Diabetes 43 ischemic strokes 43 EQUIP OB 43 GPNMB expression 43 Diabetes Interventions 43 EndoTAGTM 1 43 doxorubicin docetaxel 43 Clinical Practice Guideline 43 Dr. Gianni Belcaro 43 APOE e4 43 serum parathyroid hormone 43 neoadjuvant chemotherapy 43 NSDUH 43 endothelial dysfunction 43 prognostic indicators 43 Comorbidity 43 NAEPP 43 Markus Heilig 43 gallstone disease 43 AF Stat 43 randomized controlled clinical 43 nationally projectable 43 DAIDS 43 progressive dyspnea 43 ENDEAVOR clinical 43 Wadih Arap 43 Braunwald 43 APTIVUS ritonavir 43 Multivariate analysis 43 mammographic breast density 43 atherosclerosis regression 43 Ovarian PLCO Cancer 43 denosumab oncology 43 Thromboembolic 43 journal Hepatology 43 gastric cardia 43 AIR CF2 43 generalizability 43 Rosiglitazone Evaluated 43 Coronary calcium 43 candesartan cilexetil 43 epigenetic therapies 43 macrovascular disease 43 sorafenib Nexavar ® 43 AFib 43 PCWP 43 NTx 43 APF# Phase 43 Phase III TRIST 43 FDG PET CT 43 ATTAIN 43 QNEXA 43 baseline HbA1c 43 macroalbuminuria 43 IPAH 43 PillCam ESO video 43 Gabriel Hortobagyi MD 43 Drug Eluting Stent System 43 nonmetastatic prostate cancer 43 variance ANOVA 43 dyssynchrony 43 bone metastasis 43 newer antipsychotic medications 43 Fx #A 43 TOLAMBA 43 intestinal permeability 43 multivariable logistic regression 43 Vertebral Fracture 43 sapacitabine 43 Congenital Heart Surgery 43 Molecular Cancer 43 receiving concomitant corticosteroids 43 ARIXTRA 43 benign biliary strictures 43 unresectable stage 43 Computed Tomographic 43 IFN alfa 43 APPROVe 43 Avastin adjuvant 43 rosuvastatin 43 Neuropsychological 43 unique alkylating agent 43 carotid artery intima media 43 journal Preventive Medicine 43 serum vitamin D 43 nonfatal myocardial infarction 43 ClinicalTrials.gov Identifier NCT#